Φορτώνει......
Emerging treatment options for the management of Hodgkin’s lymphoma: clinical utility of nivolumab
Classical Hodgkin’s lymphoma (cHL) is a B-cell malignancy comprised of pathologic Reed Sternberg cells with a surrounding immune-tolerant inflammatory milieu. RS cells evade immune recognition in part through programmed death ligand 1 (PD-L1) overexpression, which is genetically programmed through c...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Blood Med |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436782/ https://ncbi.nlm.nih.gov/pubmed/28546779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S117452 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|